Pricing Log in Create free account

vTv Therapeutics Inc. (VTVT) vs VAXART, INC. (VXRT)

vTv Therapeutics Inc. and VAXART, INC. are both Biotechnology companies. vTv Therapeutics Inc. and VAXART, INC. are of similar size ($95.0M and $92.4M). vTv Therapeutics Inc. has negative trailing earnings, so its P/E is not meaningful; VAXART, INC. trades at 2.8×. vTv Therapeutics Inc. grew revenue faster over the last twelve months: 654.6% against 22.3%. VAXART, INC. has the higher net margin (16.0% vs 0.00%) and the higher return on invested capital (2,542.3% vs 0.00%). Across the 17 metrics below, VAXART, INC. leads on 15 and vTv Therapeutics Inc. on 2.

Valuation

Metric VTVT VXRT Biotechnology median
P/E n/m 2.85 10.26
P/S 7.15 0.50 9.18
P/B 3.44 1.36 2.05
Price to free cash flow n/m 2.81 24.81
EV/EBITDA n/m 0.56 0.65
EV/Sales 4.90 0.14 8.98
Earnings yield (3.53%) 35.14% (34.89%)
Free cash flow yield (6.23%) 35.55% (24.52%)

Profitability

Metric VTVT VXRT Biotechnology median
Gross margin 99.92% 100.00% 65.16%
Operating margin 0.00% 16.63% 0.00%
Net margin 0.00% 16.02% 0.00%
Free cash flow margin 0.00% 17.64% 0.00%
Return on equity (11.74%) 62.42% (50.12%)
Return on assets (8.34%) 16.26% (45.60%)
Return on invested capital 0.00% 2,542.26% 0.00%

Growth

Metric VTVT VXRT Biotechnology median
Revenue growth (TTM) 654.58% 22.31% 6.26%
EPS growth (last fiscal year) 0.00% 121.21% 29.88%
Revenue growth, 5-year CAGR (39.39%) 125.76% 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric VTVT VXRT Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 12.48 1.71 4.89
Net debt to EBITDA 2.71 (2.42) 1.01

Dividend

Metric VTVT VXRT Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric VTVT VXRT Biotechnology median
Market cap 95.02m 92.41m 172.11m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack